3D-QSAR and molecular docking studies on fused pyrazoles as p38α mitogen-activated protein kinase inhibitors

International Journal of Molecular Sciences

Volumn 11, Issue 9, 2010, Pages 3357-3374

  Lan, Ping ^a   Huang, Zhi Jian ^a   Sun, Jun Rong ^a   Chen, Wei Min ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

3D QSAR; CoMFA; CoMSIA; Docking; p38 mitogen activated protein kinase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PYRAZOLE DERIVATIVE;

ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG DESIGN; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; IC 50; MOLECULAR DOCKING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

3D-QSAR; COMFA; COMSIA; DOCKING; P38Α MITOGEN-ACTIVATED PROTEIN KINASE;

AMINO ACID SEQUENCE; MITOGEN-ACTIVATED PROTEIN KINASE 14; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PYRAZOLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77958466860     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11093357     Document Type: Article

References (22)

1. Pettus, L.H.; Wurz, R.P.; Xu, S.; Herberich, B.; Henkle, B.; Liu, Q.; McBride, H.J.; Mu, S.; Plant, M.H.; Saris, C.J.M.; Sherman, L.; Wong, L.M.; Chmait, S.; Lee, M.R.; Mohr, C.; Hsieh, F.; Tasker, A.S. Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38a mitogen-activated protein kinase. J. Med. Chem. 2010, 53, 2973-2985.
2. Wurz, R.P.; Pettus, L.H.; Henkle, B.; Sherman, L.; Plant, M.; Miner, K.; McBride, H.J.; Wong, L.M.; Saris, C.J.M.; Lee, M.R.; Chmait, S.; Mohr, C.; Hsieh, F.; Tasker, A.S. Part2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38a mitogen-activated protein kinase. Bioorg. Med. Chem. Lett. 2010, 20, 1680-1684.
3. Wurz, R.P.; Pettus, L.H.; Xu, S.; Henkle, B.; Sherman, L.; Plant, M.; Miner, K.; McBride, H.; Wong, L.M.; Saris, C.J.M.; Lee, M.R.; Chmait, S.; Mohr, C.; Hsieh, F.; Tasker, A.S. Part 1: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38a mitogen-activated protein kinase. Bioorg. Med. Chem. Lett. 2009, 19, 4724-4728.
4. Hynes, J., Jr.; Dyckman, A.J.; Lin, S.; Wrobleski, S.T.; Wu, H.; Gillooly, K.M.; Kanner, S.B.; Lonial, H.; Loo, D.; McIntyre, K.W.; Pitt, S.; Shen, D.R.; Shuster, D.J.; Yang, S.; Zhang, R.; Behnia, K.; Zhang, H.; Marathe, P.H.; Doweyko, A.M.; Tokarski, J.S.; Sack, J.S.; Pokross, M.; Kiefer, S.E.; Newitt, J.A.; Barrish, J.C.; Dodd, J.; Schieven, G.L.; Leftheris, K. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38a mitogen-activated protein kinase inhibitors. J. Med. Chem. 2008, 51, 4-16.
5. Pettus, L.H.; Xu, S.; Cao, G.-Q.; Chakrabarti, P.P.; Rzasa, R.M.; Sham, K.; Wurz, R.P.; Zhang, D.; Middleton, S.; Henkle, B.; Plant, M.H.; Saris, C.J.M.; Sherman, L.; Wong, L.M.; Powers, D.A.; Tudor, Y.; Yu, V.; Lee, M.R.; Syed, R.; Hsieh, F.; Tasker, A.S. 3-Amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38a mitogen-activated protein kinase. J. Med. Chem. 2008, 51, 6280-6292.
6. Laufer, S.A.; Hauser, D.R.J.; Domeyer, D.M.; Kinkel, K.; Liedtke, A.J. Design, synthesis, and biological evaluation of novel tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38a mitogen-activated protein kinase: Focus on optimized interactions with the enzyme's surface-exposed front region. J. Med. Chem. 2008, 51, 4122-4149.
7. Koch, P.; Jahns, H.; Schattel, V.; Goettert, M.; Laufer, S. Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38a mitogen-activated protein kinase inhibitors. J. Med. Chem. 2010, 53, 1128-1137.
8. Thaher, B.A.; Koch, P.; Schattel, V.; Laufer, S. Role of the hydrogen bonding heteroatom-lys53 interaction between the p38a mitogen-activated protein (MAP) kinase and pyridinyl-substituted 5-membered heterocyclic ring inhibitors. J. Med. Chem. 2009, 52, 2613-2617.
9. Lumeras, W.; Caturla, F.; Vidal, L; Esteve, C.; Balague, C.; Orellana, A.; Dominguez, M.; Roca, R.; Huerta, J.M.; Godessart, N.; Vidal, B. Design, synthesis, and structure-activity relationship of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38a mitogen-activated protein kinase. J. Med. Chem. 2009, 52, 5531-5545.
10. Hauser, D.R.J.; Scior, T.; Domeyer, D.M.; Kammerer, B.; Laufer, S.A. Synthesis, biological testing, and binding mode prediction of 6,9-diarylpurin-8-ones as p38a MAP kinase inhibitors. J. Med. Chem. 2007, 50, 2060-2066.
11. Peifer, C.; Kinkel, K.; Abadleh, M.; Schollmeyer, D.; Laufer, S. From five- to six- membered rings: 3,4-diarylquinolinone as lead for novel p38a MAP kinase inhibitors. J. Med. Chem. 2007, 50, 1213-1221.
12. Sybyl 8.1; Tripos Inc.: St. Louis, MO, USA, 2008. Available online: http://www.tripos.com (accessed on 11 September 2010).
13. Yang, Z.; Sun, P. 3D-QSAR study of potent inhibitors of phosphodiesterase-4 using a CoMFA approach. Int. J. Mol. Sci. 2007, 9, 714-722.
14. Sun, J.; Cai, S.; Yan, N.; Mei, H. Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis. Eur. J. Med. Chem. 2010, 45, 1008-1014.
15. Zhang, N.; Zhong, R. Docking and 3D-QSAR studies of 7-hydroxycoumarin derivatives as CK2 inhibitors. Eur. J. Med. Chem. 2010, 45, 292-297.
16. Zhou, Z.; Wang, Y.; Bryant, S.H. QSAR models for predicting cathepsin B inhibition by small molecules continuous and binary QSAR model to classify cathepsin B inhibition activities of small molecules. J. Mol. Grap. Model. 2010, 28, 714-727.
17. Sivan, S.K.; Manga, V. Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J. Mol. Model. 2010, 16, 1169-1178.
18. Song, Q.-L.; Sun, P.-H.; Chen, W.-M. Exploring 3D-QSAR for ketolide derivatives as antibacterial agents using CoMFA and CoMSIA. Lett. Drug Des. Discov. 2010, 7, 149-159.
19. Morshed, M.N.; Muddassar, M.; Pasha, F.A.; Cho, S.J. Pharmacophore identification and validation study of CK2 inhibitors using CoMFA/CoMSIA. Chem. Biol. Drug Des. 2009, 74, 148-158.
20. Zeng, H.; Cao, R.; Zhang, H. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin. Chem. Biol. Drug Des. 2009, 74, 596-610.
21. Roy, K.; Pau, S. Docking and 3D-QSAR studies of acetohydroxy acid synthase inhibitor sulfonylurea derivatives. J. Mol. Model. 2010, 16, 951-964.
22. Srivastava, V.; Gupta, S.P.; Siddiqi, M.I.; Mishra, B.N. 3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models. Eur. J. Med. Chem. 2010, 45, 1560-1571.